White Paper | Formulation and Manufacturing Approaches for Nasal Drug Products

Benefits, Challenges and Considerations

Nasal drug products present significant opportunities to deliver treatments topically or systemically via innovative formulations or device designs to treat a variety of conditions. These products vary in device type and formulation (solution / suspension / dry powder) and can be an ideal platform for the delivery of both small and large molecules. 

In this whitepaper, David Ward, Intertek’s Formulation and Manufacture Lead, introduces nasal drug products, including the benefits of this platform, regulatory considerations and approaches to overcome the challenges of development, formulation and manufacturing approaches.

Please complete the form below to download the white paper.